APW
RVMD icon

Aventura Private Wealth’s Revolution Medicines RVMD Stock Holding History

Aventura Private Wealth’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Hold
81
– – ﹤0.01% 528
2026
Q1 		$7.88K Hold
81
– – ﹤0.01% 576
2025
Q4 		$6.45K Hold
81
– – ﹤0.01% 565
2025
Q3 		$3.78K Hold
81
– – ﹤0.01% 616
2025
Q2 		$2.98K Hold
81
– – ﹤0.01% 588
2025
Q1 		$2.86K Hold
81
– – ﹤0.01% 575
2024
Q4 		$3.54K Buy
+81
New +$4.09K ﹤0.01% 535

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Aventura Private Wealth's RVMD Position: Q2 2026 in Review

Aventura Private Wealth held its Revolution Medicines (RVMD) position steady in Q2 2026 at 81 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #528.

Aventura Private Wealth first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Aventura Private Wealth held 81 shares of Revolution Medicines worth $15.2K as of Q2 2026.
  • Aventura Private Wealth left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #528 holding.
  • Aventura Private Wealth first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.